| Literature DB >> 21871104 |
Joseph B Mabula1, Mheta Koy2, Mabula D Mchembe3, Hyasinta M Jaka2, Rodrick Kabangila2, Alphonce B Chandika1, Japhet M Gilyoma1, Phillipo L Chalya1.
Abstract
BACKGROUND: Perforated peptic ulcer is a serious complication of peptic ulcers with potential risk of grave complications. There is paucity of published reports on perforated peptic ulcer disease in our local environment. This study was conducted to evaluate the clinical presentation, management and outcome of patients with peptic ulcer perforation in our setting and to identify predictors of outcome of these patients.Entities:
Year: 2011 PMID: 21871104 PMCID: PMC3179712 DOI: 10.1186/1749-7922-6-31
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Clinical presentation
| Clinical presentation | Frequency | Percentage |
|---|---|---|
| Severe abdominal pain | 82 | 97.6 |
| Abdominal distention | 64 | 76.2 |
| Vomiting | 31 | 36.9 |
| Nausea | 30 | 35.7 |
| Severe dyspepsia | 28 | 33.3 |
| Constipation | 25 | 29.8 |
| Fever | 18 | 21.4 |
| Shock | 28 | 33.3 |
| Abdominal tenderness | 74 | 88.1 |
| Classical signs of peritonitis | 56 | 66.7 |
Post-operative complications (N = 25)
| Complications | Frequency | Percentage |
|---|---|---|
| Surgical site infections | 12 | 48.0 |
| Post-operative pyrexia | 9 | 36.0 |
| Pulmonary infection | 7 | 28.0 |
| Intra-abdominal abscess | 5 | 20.0 |
| Wound dehiscence/burst abdomen | 5 | 20.0 |
| Re-perforation | 4 | 16.0 |
| Septic shock | 3 | 12.0 |
| Enterocutaneous fistula | 3 | 12.0 |
| Peritonitis | 3 | 12.0 |
| Incisional hernia | 2 | 8.0 |
| Cardiopulmonary arrest | 2 | 8.0 |
| Acute renal failure | 1 | 4.0 |
| Paralytic ileus | 1 | 4.0 |
Predictors of complications according to univariate and multivariate logistic regression analysis
| Predictor(independent) variable | Complication N (%) | No complication n (%) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
| p-value | p-value | |||||
| <40 | 15 (28.8) | 37 (71.2) | ||||
| ≥40 | 10 (31.2) | 22 (68.8) | 3.91(0.94-5.23) | 0.167 | 1.23(0.93-2.34) | 0.786 |
| Male | 14 (29.2) | 36 (70.8) | ||||
| Female | 11 (30.6) | 25 (69.4) | 1.87(0.22-4.88) | 0.334 | 3.32(0.45-4.66) | 0.937 |
| Yes | 4 (66.7) | 2(33.3) | ||||
| No | 21(26.9) | 57(73.1) | 3.54(1.33-5.87) | 0.012 | 5.28(2.39-6.82) | |
| Yes | 7(26.9) | 19(73.1) | ||||
| No | 18(31.0) | 40(69.0) | 0.21(0.11-1.78) | 0.051 | 1.65(0.32-2.89) | 0.786 |
| Yes | 3(33.3) | 6(66.7) | ||||
| No | 22(29.3) | 53(70.7) | 1.98(0.99-3.91) | 0.923 | 1.02(0.78-3.90) | 0.123 |
| Yes | 22(30.6) | 50(69.4) | ||||
| No | 3(25.0) | 9(75.0) | 3.05(0.19-2.86) | 0.054 | 0.45(0.22-5.21) | 0.321 |
| Yes | 17(31.5) | 37(68.5) | ||||
| No | 8(26.7) | 22(73.3) | 3.11(0.44-5.23) | 0.145 | 3.02(0.99-4.56) | 0.334 |
| < 48 | 18(90.0) | 2(10.0) | ||||
| ≥ 48 | 7(14.6) | 41(85.4) | 1.06(1.01-5.45) | 0.021 | 0.23(0.11-0.95) | |
| Positive | 6(75.0) | 2 (25.0) | ||||
| Negative | 19(25.0) | 57(75.0) | 2.87(1.22-4.97) | 0.023 | 1.92(1.31-4.22 | |
| 1 (50.0) | 1(50.0) | |||||
| ≥ 200 cells/μl | 1(16.7) | 5(83.3) | 4.05(3.27-5.01) | 0.029 | 2,94(2.44-6.98) | |
| Acute | 24(32.4) | 50(67.6) | ||||
| Chronic | 1(10.0) | 9(90.0) | 4.94(2.84-8.92) | 0.009 | 2.95(1.11-6.98) | |
Predictors of mortality according to univariate and multivariate logistic regression analysis
| Predictor (independent) variable | Survivors N (%) | Non-survivors n (%) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
| O.R. (95% C.I.) | p-value | (O.R. 95% C.I.) | p-value | |||
| < 40 | 51(98.1) | 1 (1.9) | ||||
| ≥40 | 24(75.0) | 8 (25.0) | 2.33(1.25-3.42) | 0.032 | 4.61(2.72-7.91) | |
| Male | 42 (87.5) | 6 (12.5) | ||||
| Female | 33 (91.7) | 3 (8.3) | 1.25 (0.32-3.56) | 0.896 | 2.93 (0.94-3.81) | 0.983 |
| Yes | 2 (33.3) | 4 (66.7) | ||||
| No | 73 (93.6 | 5 (6.4) | 6.21(1.49-7.01) | 0.039 | 3.78(2.98-7.90) | |
| Yes | 23 (88.0) | 3(12.0) | ||||
| No | 52 (89.7) | 6 (10.3) | 1.75(0.76-4.34) | 0.896 | 3.11(0.98-4.88) | 0.345 |
| Positive | 1(12.5) | 7 (87.5) | ||||
| Negative | 74(97.4) | 2 (2.6) | 0.56(0.12-0.86) | 0.005 | 1.74(1.21-4.98) | |
| < 200 cells/μl | 1(50.0) | 1 (50.0) | ||||
| ≥ 200 cells/μl | 4(66.7) | 2 (33.3) | 5.91(2.76-7.99) | 0.001 | 1.65(1,22-7.43) | |
| <24 hours | 23 (92.0) | 2 (8.0) | ||||
| ≥24 hours | 48 (87.3) | 7 (12.7) | 2.32(0.54-6.45) | 0.986 | 0.09(0.02-1.11) | 0.315 |
| Yes | 28 (77.8) | 8 (22.2) | ||||
| No | 47 (87.9) | 1(2.1) | 7.9(3.98-9.88) | 0.022 | 3,74(2,11-7.76) | |
| 19 (95.0) | 1 (5.0) | |||||
| ≥ 48 hours | 56 (87.5) | 8 (12.5%) | 2.87(2.11-7.21) | 0.044 | 2.91(1.22-6.66) | |
| < 200 | 19 (95.0) | 1 (5.0) | ||||
| ≥200 | 56(87.5) | 8 (12.5) | 0.67(0.23-4.65) | 0.982 | 1.61(0.89-2.73) | 0.067 |
| Duodenum | 72 (93.4) | 5 (6.6) | ||||
| Gastric | 2 (33.3) | 4 (66.7) | 5.81(3.33-6.92) | 0.012 | 1.35(1.11-3.86) | |
| Sealed | 7 (100.0) | 0(0) | ||||
| <5 mm | 12 (92.3) | 1(7.7) | ||||
| ≥5 mm | 56 (87.5) | 8(12.5) | 1.98(0.45-3.82) | 0.987 | 3.13(0.99-4.89) | 0.453 |
| Present | 18 (72.0) | 7(28.0) | ||||
| Absent | 57(96.6) | 2 (3.4) | 1.98(1.54-7.93) | 0.005 | 2.86(2.22-6.45) | |